InvestorsHub Logo
Followers 30
Posts 1475
Boards Moderated 0
Alias Born 07/10/2013

Re: changes_iv post# 42627

Wednesday, 10/06/2021 4:03:00 AM

Wednesday, October 06, 2021 4:03:00 AM

Post# of 44690
I tell you from my side why the acceptance for filing is in my eyes so relevant.

I was doubting after all the stories of Dr. J and Dr. Ram that RELIEF is ready to perform a filing act on their own ! The process of EUA/NDA of Zyesami has been so much driven by JJ - I was somewhat getting this impression. (Sorry RLF, I still love you).

Now today seeing RLF to perform a successful FDA filing is very relevant since you see that this company is able to perform this very demanding procedure.

An accepted file for NDA needs many details, starts with preclinical data, toxicology in mice, GMP production details, goes to package insert writing (very relevant) to human phase III data presentation, labeling, supply chain and a postmarketing plan etc.

Now I see that RLF is very capable, even better FDA proven to be capable, to perform such an act.

This is very reassuring and shows to me that RLF can act on its own as independent pharma company !

They have everything in place to advance to Big Pharma!

~ IG, Y@h00 RLFTF finance conversations